$0.10
2.70% day before yesterday
Nasdaq, Jan 02, 10:16 pm CET
ISIN
US03828A1016
Symbol
APLT

Applied Therapeutics, Inc. Stock price

$0.10
-0.11 51.76% 1M
-0.24 69.64% 6M
+0.00 2.70% YTD
-0.80 88.57% 1Y
-0.66 86.49% 3Y
-21.97 99.53% 5Y
-9.30 98.91% 10Y
-9.30 98.91% 20Y
Nasdaq, Closing price Fri, Jan 02 2026
+0.00 2.70%
ISIN
US03828A1016
Symbol
APLT
Industry

Key metrics

Basic
Market capitalization
$14.8m
Enterprise Value
$2.9m
Net debt
positive
Cash
$12.0m
Shares outstanding
144.3m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
14.8 | 14.5
EV/Sales
2.9 | 2.8
EV/FCF
negative
P/B
negative
Financial Health
Equity Ratio
65.8%
Return on Equity
-185.3%
ROCE
-6,694.1%
ROIC
-
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$1.0m | $1.0m
EBITDA
- | $-96.3m
EBIT
$-98.4m | $-84.8m
Net Income
$-18.1m | $-78.4m
Free Cash Flow
$-86.7m
Growth (TTM | estimate)
Revenue
-90.4% | 121.7%
EBITDA
- | 7.3%
EBIT
27.4% | 18.7%
Net Income
93.3% | 25.8%
Free Cash Flow
-5.7%
Margin (TTM | estimate)
Gross
-
EBITDA
- | -9,439.0%
EBIT
-9,840.3%
Net
-1,813.8% | -7,684.0%
Free Cash Flow
-8,668.3%
More
EPS
$-0.1
FCF per Share
$-0.6
Short interest
10.4%
Employees
35
Rev per Employee
$10.0k
Show more

Is Applied Therapeutics, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,082 stocks worldwide.

Applied Therapeutics, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

11 Analysts have issued a Applied Therapeutics, Inc. forecast:

7x Buy
64%
4x Hold
36%

Analyst Opinions

11 Analysts have issued a Applied Therapeutics, Inc. forecast:

Buy
64%
Hold
36%

Financial data from Applied Therapeutics, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
1 1
90% 90%
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 60 60
8% 8%
6,035%
- Research and Development Expense 39 39
57% 57%
3,906%
- -
-
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT -98 -98
27% 27%
-9,840%
Net Profit -18 -18
93% 93%
-1,814%

In millions USD.

Don't miss a Thing! We will send you all news about Applied Therapeutics, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Applied Therapeutics, Inc. Stock News

Neutral
Business Wire
22 days ago
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Applied Therapeutics, Inc. (NASDAQ: APLT) to Cycle Group Holdings Limited for $0.088 per share in cash plus one non-transferrable contingent value right entitling the holder to receive potential additional payments under certain conditions is fair to Applied shareholders. Halper Sadeh ...
Neutral
GlobeNewsWire
23 days ago
Applied Therapeutic's lead drug candidate, govorestat, is a novel central nervous system penetrant Aldose Reductase Inhibitor for the treatment of CNS rare metabolic diseases Applied Therapeutic's lead drug candidate, govorestat, is a novel central nervous system penetrant Aldose Reductase Inhibitor for the treatment of CNS rare metabolic diseases
Neutral
GlobeNewsWire
about one month ago
NEW YORK, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT) (the “Company”), a clinical-stage biopharmaceutical company dedicated to creating transformative treatments for rare diseases, today announced that Applied Therapeutics' Board of Directors (the “Board”) has initiated a process to explore strategic alternatives for the Company. The Board intends to evaluate a b...
More Applied Therapeutics, Inc. News

Company Profile

Applied Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company was founded by Shoshana Shendelman on January 20, 2016 and is headquartered in New York, NY.

Head office United States
CEO Les Funtleyder
Employees 35
Founded 2016
Website www.appliedtherapeutics.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today